Cargando…

CRIPTO Is a Marker of Chemotherapy-Induced Stem Cell Expansion in Non-Small Cell Lung Cancer

Chemotherapy is the mainstay for the treatment of non-small cell lung cancer (NSCLC). However, NSCLC cells are either intrinsically chemoresistant or rapidly develop therapy resistance. Cancer stem cells (CSCs) are widely recognized as the cell population responsible for resistance to systemic thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francescangeli, Federica, De Angelis, Maria Laura, Rossi, Rachele, Sette, Giovanni, Eramo, Adriana, Boe, Alessandra, Guardiola, Ombretta, Tang, Tao, Yu, Shi-Cang, Minchiotti, Gabriella, Zeuner, Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200964/ https://www.ncbi.nlm.nih.gov/pubmed/35719935 http://dx.doi.org/10.3389/fonc.2022.830873

Ejemplares similares

Conditional Cripto overexpression in satellite cells promotes myogenic commitment and enhances early regeneration
por: Prezioso, Carolina, et al.
Publicado: (2015)

Cripto shapes macrophage plasticity and restricts EndMT in injured and diseased skeletal muscle
por: Iavarone, Francescopaolo, et al.
Publicado: (2020)

Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer
por: Francescangeli, F, et al.
Publicado: (2015)

Cripto is essential to capture mouse epiblast stem cell and human embryonic stem cell pluripotency
por: Fiorenzano, Alessandro, et al.
Publicado: (2016)

Biomanufacturing Recombinantly Expressed Cripto-1 Protein in Anchorage-Dependent Mammalian Cells Growing in Suspension Bioreactors within a Three-Dimensional Hydrogel Microcarrier
por: Lev, Rachel, et al.
Publicado: (2023)

Lung Cancer Organoids: The Rough Path to Personalized Medicine
por: Rossi, Rachele, et al.
Publicado: (2022)

Nodal-dependent Cripto signaling promotes cardiomyogenesis and redirects the neural fate of embryonic stem cells
por: Parisi, Silvia, et al.
Publicado: (2003)

A pre-existing population of ZEB2(+) quiescent cells with stemness and mesenchymal features dictate chemoresistance in colorectal cancer
por: Francescangeli, Federica, et al.
Publicado: (2020)

Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19
por: De Angelis, Maria Laura, et al.
Publicado: (2021)

Cripto Is Targeted by miR-1a-3p in a Mouse Model of Heart Development
por: Angrisano, Tiziana, et al.
Publicado: (2023)

COVID-19–Induced Modifications in the Tumor Microenvironment: Do They Affect Cancer Reawakening and Metastatic Relapse?
por: Francescangeli, Federica, et al.
Publicado: (2020)

Cripto promotes A–P axis specification independently of its stimulatory effect on Nodal autoinduction
por: D'Andrea, Daniela, et al.
Publicado: (2008)

Dietary Factors in the Control of Gut Homeostasis, Intestinal Stem Cells, and Colorectal Cancer
por: Francescangeli, Federica, et al.
Publicado: (2019)

Breast Cancer Stem Cells as Drivers of Tumor Chemoresistance, Dormancy and Relapse: New Challenges and Therapeutic Opportunities
por: De Angelis, Maria Laura, et al.
Publicado: (2019)

The Multifaceted Roles of Proline in Cell Behavior
por: Patriarca, Eduardo J., et al.
Publicado: (2021)

Dormancy, stemness, and therapy resistance: interconnected players in cancer evolution
por: Francescangeli, Federica, et al.
Publicado: (2023)

Colorectal Cancer Stem Cells: An Overview of Evolving Methods and Concepts
por: De Angelis, Maria Laura, et al.
Publicado: (2021)

The Ultrastructural Analysis of Human Colorectal Cancer Stem Cell-Derived Spheroids and Their Mouse Xenograft Shows That the Same Cells Types Have Different Ratios
por: Relucenti, Michela, et al.
Publicado: (2021)

Stem Cell Plasticity and Dormancy in the Development of Cancer Therapy Resistance
por: De Angelis, Maria Laura, et al.
Publicado: (2019)

Cripto-1 in TNBC
por: Castro, Nadia P, et al.
Publicado: (2015)

COVID-19: a potential driver of immune-mediated breast cancer recurrence?
por: Francescangeli, Federica, et al.
Publicado: (2020)

Cripto-1 vaccination elicits protective immunity against metastatic melanoma
por: Ligtenberg, M. A., et al.
Publicado: (2016)

Expression of cripto in Human Pancreatic Tumors
por: Tsutsumi, Masahiro, et al.
Publicado: (1994)

Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
por: Ishii, Hiroko, et al.
Publicado: (2021)

Autoregulation and Heterogeneity in Expression of Human Cripto-1
por: Loying, Pojul, et al.
Publicado: (2015)

CRIPTO-1 Is Immunolocalized in the Syncytiotrophoblast of Ampullary Pregnancies
por: Cabar, Fábio Roberto, et al.
Publicado: (2022)

A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells
por: Orienti, Isabella, et al.
Publicado: (2019)

Cripto-1 Promotes the Epithelial-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma Cells
por: Huang, Chun, et al.
Publicado: (2015)

An organoid model of colorectal circulating tumor cells with stem cell features, hybrid EMT state and distinctive therapy response profile
por: De Angelis, Maria Laura, et al.
Publicado: (2022)

Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model
por: Alam, Md Jahangir, et al.
Publicado: (2018)

Analysis of Dormancy-Associated Transcriptional Networks Reveals a Shared Quiescence Signature in Lung and Colorectal Cancer
por: Cuccu, Adriano, et al.
Publicado: (2022)

Expression and functional role of CRIPTO-1 in cutaneous melanoma
por: De Luca, A, et al.
Publicado: (2011)

Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma
por: Wu, Zhengrong, et al.
Publicado: (2009)

Cripto haploinsufficiency affects in vivo colon tumor development
por: GIORGIO, EMILIA, et al.
Publicado: (2014)

Clinical significance of cripto-1 expression in lung adenocarcinoma
por: Zhang, Hua, et al.
Publicado: (2017)

A new bioavailable fenretinide formulation with antiproliferative, antimetabolic, and cytotoxic effects on solid tumors
por: Orienti, Isabella, et al.
Publicado: (2019)

Enhancement of Notch receptor maturation and signaling sensitivity by Cripto-1
por: Watanabe, Kazuhide, et al.
Publicado: (2009)

Beneficial effects of Cripto-1 for transarterial chemoembolization in hepatocellular carcinoma
por: Li, Xiao-shan, et al.
Publicado: (2019)

Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal
por: Freeman, David W., et al.
Publicado: (2021)

Cripto-1 expression in patients with clear cell renal cell carcinoma is associated with poor disease outcome
por: Xue, Yi-Jun, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5lchn9ppmfi39104n3psj0tbb1